Claudia Ordonez - Chief Medical Officer at Keros Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Stock Symbol
KROS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Claudia Ordonez since 9/17/2023

Holdings reported by Claudia Ordonez for Keros Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Employee Stock Option (right to buy) 98.2K Jun 11, 2021 Direct Common Stock
Common Stock 0 $45.29 Jun 11, 2021 Direct

Transactions reported by Claudia Ordonez for Keros Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.